NCT00832364 - Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis | Biotech Hunter

Timeline

Start Date

October 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

April 30, 2010

Conditions

Plaque Psoriasis

Interventions

DRUG

Acitretin (also called U0279)

Capsules containing 25 mg U0279 taken once a day.

DRUG

Placebo

Placebo capsules

BIOLOGICAL

Etanercept

Injectable Biologic

Trial Locations (3)

Mt. Sinai School of Medicine Department of Dermatology, New York

Physicians Skin Care, Louisville

UCSF - Dermatology Psoriasis & Skin Treatment Center, San Francisco